Pindar incident
Meg: A fire broke out in some auxiliary workshops of the subsidiary, which had limited impact on the current business performance.
Gemei (002340) announced that some auxiliary workshops of the subsidiary were on fire. The fire caused no casualties. According to the field monitoring of environmental protection, the relevant atmospheric indicators are within the normal range. The company has insured related property insurance and reported the case to the insurance company, and related insurance claims are being carried out in an orderly manner. The fire has limited impact on the company's current operation and performance, and the specific losses are being verified.
Jianfa shares: It is planned to acquire no more than 30% shares of Red Star Macalline in cash and may become its controlling shareholder.
Jianfa Co., Ltd. (600 153) announced that the company intends to acquire less than 30% of the shares of Red Star Macalline Home Furnishing Group Co., Ltd. (hereinafter referred to as "Red Star Macalline") by cash agreement. After the completion of this transaction, the company may become the controlling shareholder of Red Star Macalline.
Hang Seng Electronics: The actual controller will be changed from Ma Yun to no actual controller.
Hang Seng Electronics (600570) announced that changes in the upper-level shareholding structure of Hangzhou Hang Seng Electronics Group Co., Ltd., the controlling shareholder, led to changes in the rights and interests of the actual controller of the company; This equity change does not involve changes in the number and shareholding ratio of Hang Seng Electronics shares held by Hang Seng Group. After this equity change, the controlling shareholder of Hang Seng Electronics is still Hang Seng Group, and the actual controller of Hang Seng Electronics will be changed from Ma Yun to no actual controller.
Gosbell: Stop planning major asset restructuring.
Gosbell (002848) announced the termination of issuing shares, paying cash to purchase assets, raising matching funds and related transactions. The company originally planned to purchase 0/00% equity of Qingdao Guoshu Information Technology Co., Ltd./KLOC by issuing shares and paying cash, and at the same time planned to raise matching funds from Weifang Bintou, the controlling shareholder, by way of inquiry. The company originally expected that this transaction would constitute a major asset restructuring.
2345: Shanghai Yanhe intends to transfer 9.68% shares of the company at a premium to become the controlling shareholder.
2345 (002 195) announced that Shanghai Yanhe Technology Partnership (Limited Partnership) will accept 554 million shares of the company transferred by Han Meng and Zhang Shuxia through agreement (accounting for 9.68% of the total share capital), and the total transfer price is 2 billion yuan, equivalent to 3.6 1 share (2345' s current share price is. After the completion of this equity change, Shanghai Yanhe Technology Partnership (Limited Partnership) will become the controlling shareholder of the company, and Ye Ke and Fu will become the actual controllers of the company.
Yiling Pharmaceutical Co., Ltd.: Lianhua Qingwen Capsule (Granule) was included in the diagnosis and treatment plan of novel coronavirus infection (tenth edition for trial implementation).
Yiling Pharmaceutical Co., Ltd. (002603) announced that recently, the National Health and Wellness Commission and state administration of traditional chinese medicine jointly issued the novel coronavirus Infection Diagnosis and Treatment Plan (Trial Tenth Edition). Lianhua Qingwen Capsule, a Chinese patent medicine produced by the company, and Lianhua Qingwen Granule, a Chinese patent medicine produced by Beijing Yiling Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, are listed as light and medium-sized recommended drugs for TCM treatment in this scheme.
View performance
Li San, Guizhou: In 2022, the net profit increased by 29%-43%, and the demand for open-mouthed arrow spray increased greatly in February.
Guizhou Lisan (603439) announced that it is estimated that the net profit returned to the mother in 2022 will be 1.96 million yuan -2 1.7 million yuan, up by 28.75438+0%-42.50% year-on-year. In the first three quarters of 2022, the company's financial indicators such as operating income and net profit grew slowly. However, since June+February, 5438, the domestic demand for drugs related to infection treatment in novel coronavirus has greatly increased, and the market demand for the company's core products, Kaikoujian Spray and Kaikoujian Spray (children's type), has greatly increased.
Meihua Bio: In 2022, the net profit increased by 70% to 9 1%.
Meihua Bio (600873) announced that in 2022, the company expects to realize a net profit attributable to shareholders of listed companies of 4 billion to 4.5 billion yuan, up 70% to 9 1% year-on-year. In 2022, the prices of main products such as monosodium glutamate, lysine, xanthan gum and other feed amino acid products rose, and the overall profitability of the company's main products further improved, thus bringing profit growth.
Increase or decrease holdings
AVIC Heavy Machinery: AVIC Finance intends to reduce its shareholding in the company.
AVIC Heavy Machinery (600765) announced that AVIC Finance intends to exchange its company shares for shares of securities investment funds such as Guotai CSI Military ETF within six months, and reduce its holdings by no more than 29.4459 million shares of AVIC Heavy Machinery (accounting for 2.00% of the company's total share capital).